| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |